$CBL
CBL & ASSOCIATES PROPERTIES INC

2021 Q1 Form 10-Q Financial Statement

#000156459021028363 Filed on May 17, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q1
Revenue $133.2M $167.6M
YoY Change -20.52% -15.38%
Cost Of Revenue $49.13M $55.37M
YoY Change -11.25% -10.23%
Gross Profit $84.05M $112.2M
YoY Change -25.1% -17.71%
Gross Profit Margin 63.11% 66.96%
Selling, General & Admin $12.61M $17.84M
YoY Change -29.29% -18.95%
% of Gross Profit 15.01% 15.9%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $48.11M $55.90M
YoY Change -13.94% -19.9%
% of Gross Profit 57.24% 49.82%
Operating Expenses $60.72M $73.90M
YoY Change -17.83% -72.27%
Operating Profit $23.33M $38.31M
YoY Change -39.12% -129.45%
Interest Expense $24.13M $46.99M
YoY Change -48.65% -12.97%
% of Operating Profit 103.45% 122.65%
Other Income/Expense, Net $4.718M -$43.96M
YoY Change -110.73% -303.44%
Pretax Income -$27.53M -$138.8M
YoY Change -80.16% 197.34%
Income Tax $751.0K $526.0K
% Of Pretax Income
Net Earnings -$26.76M -$122.7M
YoY Change -78.18% 214.74%
Net Earnings / Revenue -20.09% -73.21%
Basic Earnings Per Share
Diluted Earnings Per Share -$136.2K -$684.8K
COMMON SHARES
Basic Shares Outstanding 175.6M
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q1 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $84.66M $159.1M
YoY Change -46.8% 655.72%
Cash & Equivalents $84.65M $159.1M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $80.59M $72.16M
Other Receivables $8.026M $10.15M
Total Short-Term Assets $173.3M $241.4M
YoY Change -28.23% 136.07%
LONG-TERM ASSETS
Property, Plant & Equipment $3.431B $3.892B
YoY Change -11.86% -15.55%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $504.6M $299.8M
YoY Change 68.3% 8.09%
Other Assets $83.51M $26.01M
YoY Change 221.09% 83.54%
Total Long-Term Assets $4.107B $4.480B
YoY Change -8.33% -11.46%
TOTAL ASSETS
Total Short-Term Assets $173.3M $241.4M
Total Long-Term Assets $4.107B $4.480B
Total Assets $4.280B $4.721B
YoY Change -9.34% -8.54%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $185.7M $205.5M
YoY Change -9.61% -25.89%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $185.7M $205.5M
YoY Change -9.61% -25.89%
LONG-TERM LIABILITIES
Long-Term Debt $1.037B $3.790B
YoY Change -72.64% -2.79%
Other Long-Term Liabilities $2.551B
YoY Change
Total Long-Term Liabilities $3.588B $3.790B
YoY Change -5.31% -3.4%
TOTAL LIABILITIES
Total Short-Term Liabilities $185.7M $205.5M
Total Long-Term Liabilities $3.588B $3.790B
Total Liabilities $3.775B $3.995B
YoY Change -5.52% -4.89%
SHAREHOLDERS EQUITY
Retained Earnings -$1.284B
YoY Change 20.1%
Common Stock $1.920M
YoY Change 10.66%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $505.5M $695.8M
YoY Change
Total Liabilities & Shareholders Equity $4.280B $4.721B
YoY Change -9.34% -8.54%

Cashflow Statement

Concept 2021 Q1 2020 Q1
OPERATING ACTIVITIES
Net Income -$26.76M -$122.7M
YoY Change -78.18% 214.74%
Depreciation, Depletion And Amortization $48.11M $55.90M
YoY Change -13.94% -19.9%
Cash From Operating Activities $62.77M $38.73M
YoY Change 62.08% -30.2%
INVESTING ACTIVITIES
Capital Expenditures -$6.865M -$22.76M
YoY Change -69.84% -13.88%
Acquisitions
YoY Change
Other Investing Activities $364.0K $290.0K
YoY Change 25.52% -9.66%
Cash From Investing Activities -$2.564M -$172.6M
YoY Change -98.51% -1356.69%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $3.000K
YoY Change -82.35%
Debt Paid & Issued, Net $84.55M
YoY Change
Cash From Financing Activities -13.76M 260.0M
YoY Change -105.29% -419.68%
NET CHANGE
Cash From Operating Activities 62.77M 38.73M
Cash From Investing Activities -2.564M -172.6M
Cash From Financing Activities -13.76M 260.0M
Net Change In Cash 46.45M 126.1M
YoY Change -63.16% -1142.23%
FREE CASH FLOW
Cash From Operating Activities $62.77M $38.73M
Capital Expenditures -$6.865M -$22.76M
Free Cash Flow $69.63M $61.49M
YoY Change 13.25% -24.94%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q4 cbl Debtor In Possession Available For Sale Securities Amortized Cost
DebtorInPossessionAvailableForSaleSecuritiesAmortizedCost
233053000
CY2021Q1 cbl Debtor In Possession Contractual Interest Expense On Prepetition Liabilities Not Recognized In Statement Of Operations
DebtorInPossessionContractualInterestExpenseOnPrepetitionLiabilitiesNotRecognizedInStatementOfOperations
44764000
CY2021Q1 cbl Debtor In Possession Available For Sale Securities Amortized Cost
DebtorInPossessionAvailableForSaleSecuritiesAmortizedCost
232774000
CY2021Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P5Y
CY2021Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P15Y
CY2021Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P20Y
CY2021Q1 us-gaap Other Income
OtherIncome
3350000
CY2020Q1 us-gaap Other Income
OtherIncome
4309000
CY2021Q1 us-gaap Revenues
Revenues
133184000
CY2020Q1 us-gaap Revenues
Revenues
167574000
CY2021Q1 us-gaap Cost Of Other Property Operating Expense
CostOfOtherPropertyOperatingExpense
21802000
CY2020Q1 us-gaap Cost Of Other Property Operating Expense
CostOfOtherPropertyOperatingExpense
25709000
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
48112000
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
55902000
CY2021Q1 us-gaap Real Estate Tax Expense
RealEstateTaxExpense
16551000
CY2020Q1 us-gaap Real Estate Tax Expense
RealEstateTaxExpense
18448000
CY2020Q1 us-gaap Cost Of Property Repairs And Maintenance
CostOfPropertyRepairsAndMaintenance
11208000
CY2021Q1 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
57182000
CY2021Q1 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-858000
CY2020Q1 us-gaap Other General Expense
OtherGeneralExpense
158000
CY2021Q1 us-gaap Costs And Expenses
CostsAndExpenses
166182000
CY2020Q1 us-gaap Costs And Expenses
CostsAndExpenses
262905000
CY2021Q1 us-gaap Investment Income Net
InvestmentIncomeNet
776000
CY2020Q1 us-gaap Investment Income Net
InvestmentIncomeNet
2397000
CY2021Q1 us-gaap Contractual Interest Expense On Prepetition Liabilities Not Recognized In Statement Of Operations
ContractualInterestExpenseOnPrepetitionLiabilitiesNotRecognizedInStatementOfOperations
44764000
CY2021Q1 us-gaap Interest Expense
InterestExpense
24130000
CY2020Q1 us-gaap Interest Expense
InterestExpense
46992000
CY2021Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
55131000
CY2021Q1 cbl Gains Losses On Sales Of Real Estate Asset
GainsLossesOnSalesOfRealEstateAsset
-299000
CY2020Q1 cbl Gains Losses On Sales Of Real Estate Asset
GainsLossesOnSalesOfRealEstateAsset
140000
CY2021Q1 us-gaap Reorganization Items
ReorganizationItems
22933000
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
751000
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
526000
CY2021Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-3076000
CY2020Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1018000
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4718000
CY2020Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-43963000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-28280000
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-139294000
CY2021Q1 us-gaap Noncontrolling Interest In Net Income Loss Operating Partnerships Redeemable
NoncontrollingInterestInNetIncomeLossOperatingPartnershipsRedeemable
-698000
CY2020Q1 us-gaap Noncontrolling Interest In Net Income Loss Operating Partnerships Redeemable
NoncontrollingInterestInNetIncomeLossOperatingPartnershipsRedeemable
-16414000
CY2021Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-819000
CY2020Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-207000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-26763000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-122673000
CY2020Q1 cbl Preferred Dividends Undeclared
PreferredDividendsUndeclared
11223000
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-26763000
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-133896000
CY2021Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.14
CY2020Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.75
CY2021Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
196509
CY2020Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
179133
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-28280000
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-139294000
CY2021Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
21000
CY2020Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
22000
CY2021Q1 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
28259000
CY2020Q1 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
139272000
CY2021Q1 cbl Operating Partnership Comprehensive Income Net Of Tax
OperatingPartnershipComprehensiveIncomeNetOfTax
698000
CY2020Q1 cbl Operating Partnership Comprehensive Income Net Of Tax
OperatingPartnershipComprehensiveIncomeNetOfTax
16412000
CY2021Q1 cbl Other Consolidated Subsidiaries Comprehensive Income Net Of Tax
OtherConsolidatedSubsidiariesComprehensiveIncomeNetOfTax
-819000
CY2020Q1 cbl Other Consolidated Subsidiaries Comprehensive Income Net Of Tax
OtherConsolidatedSubsidiariesComprehensiveIncomeNetOfTax
-207000
CY2020Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17836000
CY2020Q1 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
133644000
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12612000
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-26742000
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-122653000
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
861865000
CY2020Q1 cbl Net Income Loss Excluding Amount Recognized In Temporary Equity
NetIncomeLossExcludingAmountRecognizedInTemporaryEquity
-138136000
CY2020Q1 us-gaap Other Comprehensive Income Other Net Of Tax
OtherComprehensiveIncomeOtherNetOfTax
22000
CY2020Q1 us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
16333947
CY2020Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1633345
CY2020Q1 cbl Stock Issued During Period Value Common Stockand Restricted Stock Award Gross
StockIssuedDuringPeriodValueCommonStockandRestrictedStockAwardGross
537000
CY2020Q1 us-gaap Stock Issued During Period Shares Restricted Stock Award Forfeited
StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited
116781
CY2020Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
97000
CY2020Q1 cbl Amortization Of Deferred Compensation
AmortizationOfDeferredCompensation
633000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition
390000
CY2020Q1 cbl Adjustments To Additional Paid In Capital Noncontrolling Interest Other
AdjustmentsToAdditionalPaidInCapitalNoncontrollingInterestOther
-60000
CY2020Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
731000
CY2020Q1 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
668000
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
725091000
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
534297000
CY2021Q1 cbl Net Income Loss Excluding Amount Recognized In Temporary Equity
NetIncomeLossExcludingAmountRecognizedInTemporaryEquity
-28067000
CY2021Q1 us-gaap Other Comprehensive Income Other Net Of Tax
OtherComprehensiveIncomeOtherNetOfTax
3000
CY2021Q1 us-gaap Stock Issued During Period Shares Restricted Stock Award Forfeited
StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited
111139
CY2021Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
1000
CY2021Q1 cbl Amortization Of Deferred Compensation
AmortizationOfDeferredCompensation
304000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition
93000
CY2021Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
11000
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
506618000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-28280000
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-139294000
CY2021Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
48112000
CY2020Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
55902000
CY2021Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
923000
CY2020Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1990000
CY2021Q1 us-gaap Amortization Of Above And Below Market Leases
AmortizationOfAboveAndBelowMarketLeases
58000
CY2020Q1 us-gaap Amortization Of Above And Below Market Leases
AmortizationOfAboveAndBelowMarketLeases
-687000
CY2021Q1 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
-299000
CY2020Q1 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
140000
CY2020Q1 cbl Gain Losson Insurance Proceeds
GainLossonInsuranceProceeds
511000
CY2021Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
55131000
CY2020Q1 us-gaap Noncash Project Abandonment Costs
NoncashProjectAbandonmentCosts
158000
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
395000
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1545000
CY2021Q1 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
57182000
CY2020Q1 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
133644000
CY2021Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-3076000
CY2020Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1018000
CY2021Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
2566000
CY2020Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
4235000
CY2021Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
6486000
CY2020Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2312000
CY2020Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-239000
CY2021Q1 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-11017000
CY2020Q1 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-1424000
CY2021Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
8115000
CY2020Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
3746000
CY2021Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
24181000
CY2020Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-16847000
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
62769000
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
38728000
CY2021Q1 cbl Payments To Additions To Real Estate Assets
PaymentsToAdditionsToRealEstateAssets
6865000
CY2021Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
16000
CY2020Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
1300000
CY2020Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3000
CY2020Q1 us-gaap Proceeds From Contributions From Affiliates
ProceedsFromContributionsFromAffiliates
668000
CY2021Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1000
CY2020Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
87000
CY2021Q1 us-gaap Payments Of Distributions To Affiliates
PaymentsOfDistributionsToAffiliates
11000
CY2020Q1 us-gaap Payments Of Distributions To Affiliates
PaymentsOfDistributionsToAffiliates
731000
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-13760000
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
259971000
CY2020Q1 cbl Payments To Additions To Real Estate Assets
PaymentsToAdditionsToRealEstateAssets
22760000
CY2021Q1 us-gaap Proceeds From Sale Of Real Estate Heldforinvestment
ProceedsFromSaleOfRealEstateHeldforinvestment
2510000
CY2020Q1 us-gaap Proceeds From Sale Of Real Estate Heldforinvestment
ProceedsFromSaleOfRealEstateHeldforinvestment
520000
CY2021Q1 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
136392000
CY2020Q1 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
153193000
CY2021Q1 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
135987000
CY2020Q1 us-gaap Proceeds From Insurance Settlement Investing Activities
ProceedsFromInsuranceSettlementInvestingActivities
600000
CY2021Q1 us-gaap Proceeds From Sale And Collection Of Mortgage Notes Receivable
ProceedsFromSaleAndCollectionOfMortgageNotesReceivable
224000
CY2020Q1 us-gaap Proceeds From Sale And Collection Of Mortgage Notes Receivable
ProceedsFromSaleAndCollectionOfMortgageNotesReceivable
503000
CY2021Q1 cbl Investments In And Advancesto Subsidiariesand Affiliates
InvestmentsInAndAdvancestoSubsidiariesandAffiliates
-57000
CY2020Q1 cbl Investments In And Advancesto Subsidiariesand Affiliates
InvestmentsInAndAdvancestoSubsidiariesandAffiliates
2679000
CY2021Q1 cbl Distributions In Excess Of Equity In Earnings Of Unconsolidated Affiliates
DistributionsInExcessOfEquityInEarningsOfUnconsolidatedAffiliates
2279000
CY2020Q1 cbl Distributions In Excess Of Equity In Earnings Of Unconsolidated Affiliates
DistributionsInExcessOfEquityInEarningsOfUnconsolidatedAffiliates
4668000
CY2021Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
364000
CY2020Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
290000
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2564000
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-172631000
CY2020Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
365000000
CY2021Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
13732000
CY2020Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
103582000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
46445000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
126068000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
121722000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
59058000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
168167000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
185126000
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
84655000
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
159117000
CY2021Q1 us-gaap Restricted Cash
RestrictedCash
61146000
CY2020Q1 us-gaap Restricted Cash
RestrictedCash
175000
CY2021Q1 us-gaap Escrow Deposit
EscrowDeposit
22366000
CY2020Q1 us-gaap Escrow Deposit
EscrowDeposit
25834000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
168167000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
185126000
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
14055000
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
25321000
CY2021Q1 cbl Cash Paid For Reorganization Items
CashPaidForReorganizationItems
12044000
CY2021Q1 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
24
CY2021Q1 cbl Number Of Regional Malls Open Air Centers Owned
NumberOfRegionalMallsOpenAirCentersOwned
61
CY2021Q1 cbl Number Of Regional Malls Open Air Centers Owned
NumberOfRegionalMallsOpenAirCentersOwned
61
CY2021Q1 cbl Number Of Associated Centers Owned
NumberOfAssociatedCentersOwned
23
CY2021Q1 cbl Number Of Associated Centers Owned
NumberOfAssociatedCentersOwned
23
CY2021Q1 cbl Number Of Community Centers Owned
NumberOfCommunityCentersOwned
6
CY2021Q1 cbl Number Of Community Centers Owned
NumberOfCommunityCentersOwned
6
CY2021Q1 cbl Number Of Office Buildings Owned
NumberOfOfficeBuildingsOwned
8
CY2021Q1 cbl Number Of Office Buildings Owned
NumberOfOfficeBuildingsOwned
8
CY2021Q1 us-gaap Number Of Real Estate Properties
NumberOfRealEstateProperties
98
CY2021Q1 us-gaap Reorganization Items
ReorganizationItems
22933000
CY2021Q1 us-gaap Debtor Reorganization Items Legal And Advisory Professional Fees
DebtorReorganizationItemsLegalAndAdvisoryProfessionalFees
22230000
CY2021Q1 cbl Debtor Reorganization Items Us Trustee Fees
DebtorReorganizationItemsUSTrusteeFees
703000
CY2021Q1 us-gaap Liabilities Subject To Compromise
LiabilitiesSubjectToCompromise
2551354000
CY2020Q4 us-gaap Liabilities Subject To Compromise
LiabilitiesSubjectToCompromise
2551490000
CY2021Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
44764000
CY2021Q1 cbl Debtor In Possession Investment In Real Estate Assets Gross
DebtorInPossessionInvestmentInRealEstateAssetsGross
3946604000
CY2020Q4 cbl Debtor In Possession Investment In Real Estate Assets Gross
DebtorInPossessionInvestmentInRealEstateAssetsGross
4056257000
CY2021Q1 cbl Debtor In Possession Accumulated Depreciation
DebtorInPossessionAccumulatedDepreciation
-1527017000
CY2020Q4 cbl Debtor In Possession Accumulated Depreciation
DebtorInPossessionAccumulatedDepreciation
-1544800000
CY2021Q1 cbl Debtor In Possession Investment In Real Estate Net
DebtorInPossessionInvestmentInRealEstateNet
2419587000
CY2020Q4 cbl Debtor In Possession Investment In Real Estate Net
DebtorInPossessionInvestmentInRealEstateNet
2511457000
CY2021Q1 cbl Debtor In Possession Developments In Progress
DebtorInPossessionDevelopmentsInProgress
30526000
CY2020Q4 cbl Debtor In Possession Developments In Progress
DebtorInPossessionDevelopmentsInProgress
27853000
CY2021Q1 cbl Debtor In Possession Investment In Real Estate Assets Net Of Developments In Progress
DebtorInPossessionInvestmentInRealEstateAssetsNetOfDevelopmentsInProgress
2450113000
CY2020Q4 cbl Debtor In Possession Investment In Real Estate Assets Net Of Developments In Progress
DebtorInPossessionInvestmentInRealEstateAssetsNetOfDevelopmentsInProgress
2539310000
CY2021Q1 cbl Debtor In Possession Available For Sale Securities At Fair Value
DebtorInPossessionAvailableForSaleSecuritiesAtFairValue
232795000
CY2020Q4 cbl Debtor In Possession Available For Sale Securities At Fair Value
DebtorInPossessionAvailableForSaleSecuritiesAtFairValue
233071000
CY2021Q1 cbl Debtor In Possession Cash And Cash Equivalents At Carrying Value
DebtorInPossessionCashAndCashEquivalentsAtCarryingValue
67279000
CY2020Q4 cbl Debtor In Possession Cash And Cash Equivalents At Carrying Value
DebtorInPossessionCashAndCashEquivalentsAtCarryingValue
46346000
CY2021Q1 cbl Debtor In Possession Restricted Cash
DebtorInPossessionRestrictedCash
56116000
CY2020Q4 cbl Debtor In Possession Restricted Cash
DebtorInPossessionRestrictedCash
29834000
CY2021Q1 cbl Debtor In Possession Intercompany Due From Non Debtor Entities
DebtorInPossessionIntercompanyDueFromNonDebtorEntities
76648000
CY2020Q4 cbl Debtor In Possession Intercompany Due From Non Debtor Entities
DebtorInPossessionIntercompanyDueFromNonDebtorEntities
76095000
CY2021Q1 cbl Debtor In Possession Other Assets
DebtorInPossessionOtherAssets
132814000
CY2020Q4 cbl Debtor In Possession Other Assets
DebtorInPossessionOtherAssets
140241000
CY2021Q1 cbl Debtor In Possession Assets
DebtorInPossessionAssets
3015765000
CY2020Q4 cbl Debtor In Possession Assets
DebtorInPossessionAssets
3064897000
CY2021Q1 cbl Debtor In Possession Other Liabilities
DebtorInPossessionOtherLiabilities
114374000
CY2020Q4 cbl Debtor In Possession Other Liabilities
DebtorInPossessionOtherLiabilities
102910000
CY2021Q1 cbl Debtor In Possession Intercompany Due To Non Debtor Entities
DebtorInPossessionIntercompanyDueToNonDebtorEntities
5253000
CY2020Q4 cbl Debtor In Possession Intercompany Due To Non Debtor Entities
DebtorInPossessionIntercompanyDueToNonDebtorEntities
5062000
CY2021Q1 cbl Debtor In Possession Liabilities Not Subject To Compromise
DebtorInPossessionLiabilitiesNotSubjectToCompromise
119627000
CY2020Q4 cbl Debtor In Possession Liabilities Not Subject To Compromise
DebtorInPossessionLiabilitiesNotSubjectToCompromise
107972000
CY2021Q1 cbl Debtor In Possession Liabilities Subject To Compromise
DebtorInPossessionLiabilitiesSubjectToCompromise
2551354000
CY2020Q4 cbl Debtor In Possession Liabilities Subject To Compromise
DebtorInPossessionLiabilitiesSubjectToCompromise
2551490000
CY2021Q1 cbl Debtor In Possession Redeemable Noncontrolling Interests
DebtorInPossessionRedeemableNoncontrollingInterests
-2786000
CY2020Q4 cbl Debtor In Possession Redeemable Noncontrolling Interests
DebtorInPossessionRedeemableNoncontrollingInterests
-2786000
CY2021Q1 cbl Debtor In Possession Shareholders Equity
DebtorInPossessionShareholdersEquity
350954000
CY2020Q4 cbl Debtor In Possession Shareholders Equity
DebtorInPossessionShareholdersEquity
411605000
CY2021Q1 cbl Debtor In Possession Noncontrolling Interests
DebtorInPossessionNoncontrollingInterests
-3384000
CY2020Q4 cbl Debtor In Possession Noncontrolling Interests
DebtorInPossessionNoncontrollingInterests
-3384000
CY2021Q1 cbl Debtor In Possession Liabilities And Equity
DebtorInPossessionLiabilitiesAndEquity
3015765000
CY2020Q4 cbl Debtor In Possession Liabilities And Equity
DebtorInPossessionLiabilitiesAndEquity
3064897000
CY2021Q1 cbl Debtor In Possession Revenues
DebtorInPossessionRevenues
88473000
CY2021Q1 cbl Debtor In Possession Depreciation And Amortization
DebtorInPossessionDepreciationAndAmortization
34154000
CY2021Q1 cbl Debtor In Possession Loss On Impairment
DebtorInPossessionLossOnImpairment
57182000
CY2021Q1 cbl Debtor In Possession Expenses
DebtorInPossessionExpenses
45391000
CY2021Q1 cbl Debtor In Possession Investment Income Net
DebtorInPossessionInvestmentIncomeNet
1788000
CY2021Q1 cbl Debtor In Possession Interest Expense
DebtorInPossessionInterestExpense
632000
CY2021Q1 cbl Debtor In Possession Reorganization Items
DebtorInPossessionReorganizationItems
-22933000
CY2021Q1 cbl Debtor In Possession Gain Loss On Sales Of Real Estate Assets
DebtorInPossessionGainLossOnSalesOfRealEstateAssets
-299000
CY2021Q1 cbl Debtor In Possession Income Tax Expense Benefit
DebtorInPossessionIncomeTaxExpenseBenefit
751000
CY2021Q1 cbl Debtor In Possession Net Income Loss
DebtorInPossessionNetIncomeLoss
-71081000
CY2021Q1 cbl Debtor In Possession Profit Loss
DebtorInPossessionProfitLoss
-71081000
CY2021Q1 cbl Debtor In Possession Increase Decrease In Loss On Impairment
DebtorInPossessionIncreaseDecreaseInLossOnImpairment
57182000
CY2021Q1 cbl Debtor In Possession Increase Decrease In Other Operating Assets
DebtorInPossessionIncreaseDecreaseInOtherOperatingAssets
-53954000
CY2021Q1 cbl Debtor In Possession Net Cash Provided By Used In Operating Activities
DebtorInPossessionNetCashProvidedByUsedInOperatingActivities
40055000
CY2021Q1 cbl Debtor In Possession Payments To Acquire Available For Sale Securities
DebtorInPossessionPaymentsToAcquireAvailableForSaleSecurities
136392000
CY2021Q1 cbl Debtor In Possession Redemption Of Available For Sale Securities
DebtorInPossessionRedemptionOfAvailableForSaleSecurities
135987000
CY2021Q1 cbl Debtor In Possession Payments For Proceeds From Other Investing Activities
DebtorInPossessionPaymentsForProceedsFromOtherInvestingActivities
2889000
CY2021Q1 cbl Debtor In Possession Net Cash Provided By Used In Investing Activities
DebtorInPossessionNetCashProvidedByUsedInInvestingActivities
-3294000
CY2021Q1 cbl Debtor In Possession Payments Of Net Distributions From Non Debtor Subsidiaries
DebtorInPossessionPaymentsOfNetDistributionsFromNonDebtorSubsidiaries
-10428000
CY2021Q1 cbl Debtor In Possession Proceeds From Payments For Other Financing Activities
DebtorInPossessionProceedsFromPaymentsForOtherFinancingActivities
26000
CY2021Q1 cbl Debtor In Possession Net Cash Provided By Used In Financing Activities
DebtorInPossessionNetCashProvidedByUsedInFinancingActivities
10454000
CY2021Q1 cbl Debtor In Possession Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
DebtorInPossessionCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
47215000
CY2020Q4 cbl Debtor In Possession Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
DebtorInPossessionCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
76180000
CY2021Q1 cbl Debtor In Possession Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
DebtorInPossessionCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
123395000
CY2021Q1 cbl Debtor In Possession Cash And Cash Equivalents At Carrying Value
DebtorInPossessionCashAndCashEquivalentsAtCarryingValue
67279000
CY2021Q1 cbl Debtor In Possession Restricted Cash
DebtorInPossessionRestrictedCash
56116000
CY2021Q1 cbl Debtor In Possession Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
DebtorInPossessionCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
123395000
CY2021Q1 cbl Debtor In Possession Cash Paid For Reorganization Items
DebtorInPossessionCashPaidForReorganizationItems
12044000
CY2021Q1 us-gaap Property Plant And Equipment Impairment
PropertyPlantAndEquipmentImpairment
<p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Arial;font-weight:normal;text-transform:none;font-variant: normal;"><span style="text-decoration:underline;">Carrying Value of Long-Lived Assets and Investment in Unconsolidated Affiliates</span></p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:6.67%;color:#212529;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">The Company evaluates its real estate assets and investment in unconsolidated affiliates for impairment indicators whenever events or changes in circumstances indicate that the carrying value of any of its long-lived assets or investment in unconsolidated affiliates may not be recoverable. Furthermore, this evaluation is conducted no less frequently than quarterly, irrespective of changes in circumstances. The prolonged outbreak of the COVID-19 pandemic resulted in sustained closure of the Company’s properties for a period of time during 2020, as well as the cessation of the operations of certain of its tenants, which has resulted and will likely continue to result in a reduction in the revenues and cash flows of many of its properties due to the adverse financial impacts on its tenants, as well as reductions in other sources of income generated by its properties. In addition to reduced revenues, the Company’s ability to obtain sufficient financing for such properties may be impaired as well as its ability to lease or re-lease properties as a result of worsening market and economic conditions resulting from the COVID-19 pandemic.</span></p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:6.67%;color:#212529;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">As of March 31, 2021, the Company’s evaluation of impairment of real estate assets considered its estimate of cash flow declines caused by the COVID-19 pandemic, but its other assumptions, including estimated hold period, were generally unchanged given the highly uncertain environment. The worsening of estimated future cash flows due to a change in the Company’s plans, policies, or views of market and economic conditions as it relates to one or more of its properties adversely impacted by the COVID-19 pandemic could result in the recognition of substantial impairment charges on its assets, which could adversely impact its financial results. For the three months ended March 31, 2021, </span><span style="color:#000000;">the Company recorded impairment charges of $57,182 related to three of its malls. As of March 31, 2021, six other properties had </span></p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;color:#212529;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#000000;">impairment indicators; however, </span><span style="color:#000000;">no</span><span style="color:#000000;"> additional impairment charges</span><span style="color:#000000;"> were recorded</span><span style="color:#000000;">.</span><span style="color:#000000;"> For the period ended March 31, 2020, the Company recorded $</span><span style="color:#000000;">133,644</span><span style="color:#000000;"> of impairment charges for </span><span style="color:#000000;">two</span><span style="color:#000000;"> of its malls and </span><span style="color:#000000;">six</span><span style="color:#000000;"> other properties had impairment indicators as of March 31, 2020</span><span style="color:#000000;">.</span><span style="color:#000000;"> </span>No<span style="color:#000000;"> additional impairment charges were recorded.</span></p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:6.67%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of March 31, 2021, the Company’s estimates of fair value for each investment are based on a number of assumptions that are subject to economic and market uncertainties including, but not limited to, demand for space, competition for tenants, changes in market rental rates, and operating costs. Future declines in the fair value of the Company’s investments in unconsolidated affiliates, including those resulting from the adverse impact of the COVID-19 pandemic on the real estate assets owned by the unconsolidated affiliates, could result in the recognition of substantial impairment charges on its investments in unconsolidated affiliates to the extent such declines are determined to be other-than-temporary. No impairments of investments in unconsolidated affiliates were recorded in the three-month periods ended March 31, 2021 and 2020.</p>
CY2021Q1 us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
0
CY2020Q1 us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
0
CY2021Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
128175000
CY2020Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
161173000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4116000
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5224000
CY2021Q1 us-gaap Revenues
Revenues
133184000
CY2020Q1 us-gaap Revenues
Revenues
167574000
CY2021Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
24292000
CY2021Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
49420000
CY2021Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
45113000
CY2021Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
118825000
CY2021Q1 us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
71227000
CY2020Q1 us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
137394000
CY2021Q1 us-gaap Operating Lease Variable Lease Income
OperatingLeaseVariableLeaseIncome
56948000
CY2020Q1 us-gaap Operating Lease Variable Lease Income
OperatingLeaseVariableLeaseIncome
23779000
CY2021Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
128175000
CY2020Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
161173000
CY2021Q1 us-gaap Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year
LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear
280554000
CY2021Q1 us-gaap Lessor Operating Lease Payments To Be Received Next Twelve Months
LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths
333159000
CY2021Q1 us-gaap Lessor Operating Lease Payments To Be Received Two Years
LessorOperatingLeasePaymentsToBeReceivedTwoYears
280432000
CY2021Q1 us-gaap Lessor Operating Lease Payments To Be Received Three Years
LessorOperatingLeasePaymentsToBeReceivedThreeYears
225734000
CY2021Q1 us-gaap Lessor Operating Lease Payments To Be Received Four Years
LessorOperatingLeasePaymentsToBeReceivedFourYears
174939000
CY2021Q1 us-gaap Lessor Operating Lease Payments To Be Received Five Years
LessorOperatingLeasePaymentsToBeReceivedFiveYears
128599000
CY2021Q1 us-gaap Lessor Operating Lease Payments To Be Received Thereafter
LessorOperatingLeasePaymentsToBeReceivedThereafter
283197000
CY2021Q1 us-gaap Lessor Operating Lease Payments To Be Received
LessorOperatingLeasePaymentsToBeReceived
1706614000
CY2021Q1 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
988773000
CY2020Q4 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
1091745000
CY2021Q1 cbl Estimated Fair Value Of Liabilities Subject To Compromise
EstimatedFairValueOfLiabilitiesSubjectToCompromise
1862147000
CY2020Q4 cbl Estimated Fair Value Of Liabilities Subject To Compromise
EstimatedFairValueOfLiabilitiesSubjectToCompromise
1606959000
CY2021Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
38500000
CY2021Q1 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
57182000
CY2021Q1 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
57182000
CY2021Q1 cbl Number Of Malls With Impairment
NumberOfMallsWithImpairment
3
CY2020Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
114300000
CY2020Q1 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
133644000
CY2020Q1 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
133644000
CY2020Q1 cbl Number Of Malls With Impairment
NumberOfMallsWithImpairment
2
CY2021Q1 cbl Number Of Entities Equity Method Of Accounting
NumberOfEntitiesEquityMethodOfAccounting
29
CY2021Q1 cbl Numberof Joint Venture Entities
NumberofJointVentureEntities
17
CY2021Q1 us-gaap Longterm Debt Percentage Bearing Fixed Interest Amount
LongtermDebtPercentageBearingFixedInterestAmount
972553000
CY2020Q4 us-gaap Longterm Debt Percentage Bearing Fixed Interest Amount
LongtermDebtPercentageBearingFixedInterestAmount
1120203000
CY2021Q1 us-gaap Longterm Debt Percentage Bearing Variable Interest Amount
LongtermDebtPercentageBearingVariableInterestAmount
67611000
CY2020Q4 us-gaap Longterm Debt Percentage Bearing Variable Interest Amount
LongtermDebtPercentageBearingVariableInterestAmount
68061000
CY2021Q1 cbl Long Term Debt Net Excluding Deferred Financing Costs
LongTermDebtNetExcludingDeferredFinancingCosts
1040164000
CY2021Q1 us-gaap Longterm Debt Weighted Average Interest Rate
LongtermDebtWeightedAverageInterestRate
0.0504
CY2020Q4 cbl Long Term Debt Net Excluding Deferred Financing Costs
LongTermDebtNetExcludingDeferredFinancingCosts
1188264000
CY2020Q4 us-gaap Longterm Debt Weighted Average Interest Rate
LongtermDebtWeightedAverageInterestRate
0.0510
CY2021Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
3194000
CY2020Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
3433000
CY2021Q1 us-gaap Long Term Debt
LongTermDebt
1036970000
CY2020Q4 us-gaap Long Term Debt
LongTermDebt
1184831000
CY2021Q1 cbl Long Term Debt Percentage Bearing Fixed Interest Amount Subject To Compromise
LongTermDebtPercentageBearingFixedInterestAmountSubjectToCompromise
1375000000
CY2020Q4 cbl Long Term Debt Percentage Bearing Fixed Interest Amount Subject To Compromise
LongTermDebtPercentageBearingFixedInterestAmountSubjectToCompromise
1375000000
CY2021Q1 cbl Long Term Debt Percentage Bearing Variable Interest Amount Subject To Compromise
LongTermDebtPercentageBearingVariableInterestAmountSubjectToCompromise
1114676000
CY2020Q4 cbl Long Term Debt Percentage Bearing Variable Interest Amount Subject To Compromise
LongTermDebtPercentageBearingVariableInterestAmountSubjectToCompromise
1114676000
CY2021Q1 cbl Long Term Debt Net Excluding Deferred Financing Costs Subject To Compromise
LongTermDebtNetExcludingDeferredFinancingCostsSubjectToCompromise
2489676000
CY2021Q1 us-gaap Debtor In Possession Financing Interest Rate On Borrowings Outstanding
DebtorInPossessionFinancingInterestRateOnBorrowingsOutstanding
0.0725
CY2020Q4 cbl Long Term Debt Net Excluding Deferred Financing Costs Subject To Compromise
LongTermDebtNetExcludingDeferredFinancingCostsSubjectToCompromise
2489676000
CY2020Q4 us-gaap Debtor In Possession Financing Interest Rate On Borrowings Outstanding
DebtorInPossessionFinancingInterestRateOnBorrowingsOutstanding
0.0725
CY2021Q1 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
57644000
CY2020Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
57644000
CY2021Q1 us-gaap Liabilities Subject To Compromise
LiabilitiesSubjectToCompromise
2551354000
CY2020Q4 us-gaap Liabilities Subject To Compromise
LiabilitiesSubjectToCompromise
2551490000
CY2021Q1 cbl Numberof Malls Securing Credit Facility Collateral
NumberofMallsSecuringCreditFacilityCollateral
17
CY2021Q1 cbl Numberof Associated Centers Securing Credit Facility Collateral
NumberofAssociatedCentersSecuringCreditFacilityCollateral
3
CY2021Q1 cbl Number Of Subsidiaries Owned
NumberOfSubsidiariesOwned
36
CY2021Q1 cbl Line Of Credit Facility Payment Restrictions
LineOfCreditFacilityPaymentRestrictions
150,000
CY2021Q1 cbl Number Of Non Recourse Loans
NumberOfNonRecourseLoans
2
CY2021Q1 us-gaap Debt Default Longterm Debt Amount
DebtDefaultLongtermDebtAmount
825856000
CY2021Q1 cbl Deconsolidation Of Secured Loans Amount
DeconsolidationOfSecuredLoansAmount
138926000
CY2021Q1 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
330456000
CY2021Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
408399000
CY2021Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
1511219000
CY2021Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
343397000
CY2021Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
37612000
CY2021Q1 cbl Long Term Debt Maturities Repayments Of Principal After Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour
763796000
CY2021Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
3394879000
CY2021Q1 us-gaap Liabilities Subject To Compromise Period Increase Decrease
LiabilitiesSubjectToCompromisePeriodIncreaseDecrease
2489676000
CY2020 us-gaap Liabilities Subject To Compromise Period Increase Decrease
LiabilitiesSubjectToCompromisePeriodIncreaseDecrease
2489676000
CY2021Q1 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
330456000
CY2021Q1 cbl Debt Instrument Weighted Average Remaining Term To Maturity
DebtInstrumentWeightedAverageRemainingTermToMaturity
P2Y9M18D
CY2020 cbl Debt Instrument Weighted Average Remaining Term To Maturity
DebtInstrumentWeightedAverageRemainingTermToMaturity
P3Y
CY2021Q1 us-gaap Revenues
Revenues
133184000
CY2021Q1 cbl Property Operating Expenses
PropertyOperatingExpenses
49134000
CY2021Q1 us-gaap Interest Expense
InterestExpense
24130000
CY2021Q1 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
-299000
CY2021Q1 cbl Segment Profit Loss
SegmentProfitLoss
59621000
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
48112000
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12612000
CY2021Q1 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-858000
CY2021Q1 us-gaap Investment Income Net
InvestmentIncomeNet
776000
CY2021Q1 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
57182000
CY2021Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
55131000
CY2021Q1 us-gaap Reorganization Items
ReorganizationItems
22933000
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
751000
CY2021Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-3076000
CY2021Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-28280000
CY2021Q1 us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
4128000
CY2020Q1 us-gaap Revenues
Revenues
167574000
CY2020Q1 cbl Property Operating Expenses
PropertyOperatingExpenses
55365000
CY2020Q1 us-gaap Interest Expense
InterestExpense
46992000
CY2020Q1 us-gaap Other General Expense
OtherGeneralExpense
158000
CY2020Q1 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
140000
CY2020Q1 cbl Segment Profit Loss
SegmentProfitLoss
65199000
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
55902000
CY2020Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17836000
CY2020Q1 us-gaap Investment Income Net
InvestmentIncomeNet
2397000
CY2020Q1 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
133644000
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
526000
CY2020Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1018000
CY2020Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-139294000
CY2020Q1 us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
20332000
CY2021Q1 us-gaap Assets
Assets
4280187000
CY2020Q4 us-gaap Assets
Assets
4443740000
CY2021Q1 cbl Environmental Liability Insurance Maximum Coverage Per Incident
EnvironmentalLiabilityInsuranceMaximumCoveragePerIncident
10000
CY2021Q1 cbl Environmental Liability Insurance Annual Coverage Limit.
EnvironmentalLiabilityInsuranceAnnualCoverageLimit.
50000
CY2021Q1 us-gaap Guarantees Fair Value Disclosure
GuaranteesFairValueDisclosure
909000
CY2020Q4 us-gaap Guarantees Fair Value Disclosure
GuaranteesFairValueDisclosure
923000
CY2021Q1 us-gaap Malpractice Loss Contingency Letters Of Credit And Surety Bonds
MalpracticeLossContingencyLettersOfCreditAndSuretyBonds
412000
CY2020Q4 us-gaap Malpractice Loss Contingency Letters Of Credit And Surety Bonds
MalpracticeLossContingencyLettersOfCreditAndSuretyBonds
412000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
10400000
CY2021Q1 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
4000
CY2020Q1 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
7000
CY2021Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
1634000
CY2021Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y
CY2021Q1 cbl Additions To Real Estate Assets Accrued But Not Yet Paid
AdditionsToRealEstateAssetsAccruedButNotYetPaid
3190000
CY2020Q1 cbl Additions To Real Estate Assets Accrued But Not Yet Paid
AdditionsToRealEstateAssetsAccruedButNotYetPaid
19478000
CY2020Q1 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
21051000
CY2021Q1 us-gaap Cost Of Property Repairs And Maintenance
CostOfPropertyRepairsAndMaintenance
10781000

Files In Submission

Name View Source Status
0001564590-21-028363-index-headers.html Edgar Link pending
0001564590-21-028363-index.html Edgar Link pending
0001564590-21-028363.txt Edgar Link pending
0001564590-21-028363-xbrl.zip Edgar Link pending
cbl-10q_20210331.htm Edgar Link pending
cbl-10q_20210331_htm.xml Edgar Link completed
cbl-20210331.xsd Edgar Link pending
cbl-20210331_cal.xml Edgar Link unprocessable
cbl-20210331_def.xml Edgar Link unprocessable
cbl-20210331_lab.xml Edgar Link unprocessable
cbl-20210331_pre.xml Edgar Link unprocessable
cbl-ex311_9.htm Edgar Link pending
cbl-ex312_7.htm Edgar Link pending
cbl-ex313_10.htm Edgar Link pending
cbl-ex314_12.htm Edgar Link pending
cbl-ex321_13.htm Edgar Link pending
cbl-ex322_11.htm Edgar Link pending
cbl-ex323_8.htm Edgar Link pending
cbl-ex324_6.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending